Abiraterone acetate (CAS 154229-18-2) is an active pharmaceutical ingredient (API) used in treating metastatic prostate cancer by inhibiting the CYP17A1 enzyme. It is a white to off-white, non-hygroscopic powder typically manufactured to high-purity USP/EP grades.